Neuromuscular Disease: Dynamic Progress at Work

With 7 new treatments in 5 years, including some of the first approved gene therapies, the field of neuromuscular disorders is making rapid dynamic progress.

Aziz Shaibani, MD

Genetic Testing in Neuromuscular Disorders

Understanding ordering and interpretation of genetic tests is paramount for clinical management.

James P. Orengo, MD, PhD; and David R. Murdock, MD

HyperCKemia

Evaluation for elevated creatine kinase is a required skill for neurologists.

Nicholas J. Silvestri, MD; and Gil I. Wolfe, MD

Utility of Skin Biopsy in Neuromuscular Disease

Intraepidermal nerve fiber density finding can help diagnose small fiber neuropathy.

David S. Saperstein, MD

Amyotrophic Lateral Sclerosis

Integrated care provides the best quality of life.

Jonathan R. Brent, MD, PhD; and Senda Ajroud-Driss, MD

Myasthenia Gravis Treatment

Both symptomatic and maintenance treatments are available.

Thy Nguyen, MD; and Cecile L. Phan, MD

Spinal Muscular Atrophy

A devastating disease now has 2 approved breakthrough treatments available.

Wijdan Rai, MD; and Bakri Elsheikh, MBBS

Congenital Myasthenic Syndrome Treatment

Heterogeneity makes diagnosis and treatment challenging.

Stanley Jones P. Iyadurai, MD, PhD, FAAN

Sporadic Inclusion Body Myositis

An update on pathophysiology with diagnostic and treatment implications.

Matthew Varon, MD; and Pedro M. Machado, MD, PhD

Noninflammatory Myopathies

As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.

Yessar Hussain, MD; Krishna Pokala, MD; and Nancy Kuo, MS, MD

Differential Diagnosis of Distal Myopathies

The era of clinical molecular genetics has refined diagnosis and will hopefully lead to disease-modifying treatments.

Kevin J. Felice, DO

Muscle Cramps

Reliable and validated outcome measures and new treatments are needed.

Hans D. Katzberg, MD, MSc, FRCPC; and Hamid Sadeghian, MD, FRCPC

Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?

Understanding pathologic mechanisms provides test beds for finding treatments.

Arnold M. Salazar; Amanda M. Leisgang; Andrew A. Ortiz; and Jefferson W. Kinney, PhD

Epilepsy Essentials: Addressing Global Disparities in Epilepsy Care

Providing regional education is a way for epileptologists to be part of a solution.

Michelle L. Dougherty, MD, FAAN, FAES

Headache Horizons: Attack of the TACs!

Trigeminal autonomic cephalalgias can be vexing—difficult to recognize and hard to treat.

Peter McAllister, MD

Movement Disorders Moment: Asleep Deep Brain Stimulation

Image-guided image-verified deep brain stimulation implantation provides safer and more accurate electrode placement.

Chengyuan Wu, MD, MSBmE

Stroke Spotlight: Cryptogenic Stroke & Embolic Stroke of Undetermined Score

What do we know and where do we go from here?

Kimberly P. Gannon, MD, PhD

Genomics to Gene Therapy in Neurology

Recent advances in neurogenomics are changing how we practice neurology.

William Renthal, MD, PhD

Early Clinically Unsuspected Alzheimer’s Disease

Biomarkers can be important tools for diagnosis.

Georgette A. Khoury, MSN, APRN-BC; and Ira J. Goodman, MD

Convention Question: What Aspect of Sleep Hygiene Is Most Difficult For People To Achieve?